Lonza Group has had four CEOs since 2019, indicating a lack of trust in its leadership. Read why I rate LZAGY stock with a ...

Eric Drapé currently works at Laboratoire Français du Fractionnement et des Biotechnologies, as Director, Ipsen Manufacturing Ireland Ltd., as Director, and Lonza Group AG, as Director from 2025.

Mr. David W. Meline is an Independent Director at HP, Inc. and an Independent Non-Executive Director at ABB Ltd. He is on the Board of Directors at Lonza Group AG, HP, Inc., ABB Ltd. and Los ...

For the first half of 2024, Lonza reported net sales of CHF 3.06 billion and core EBITDA of CHF 893 million, representing a margin of 29.2%. Again, Integrated Biologics led with CHF 1.34 billion ...

Ad hoc announcement pursuant to Art. 53 LR The One Lonza organizational structure became effective on 1 April 2025 and comprises three CDMO Business Platforms: Integrated Biologics, Advanced Synthesis ...

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Biologics CDMO Market - A Global and Regional Analysis: Focus on Cell Type, Indication, Molecule Type, and Region - Analysis and Forecast, 2025-2035 ...

We think Lonza is positioned to deliver strong long-term performance, particularly in the fast-growing integrated biologics and specialized modalities segments. Management anticipates its CDMO ...

compared to their contribution of 11% to Biologics Revenues. The financials provide a comprehensive view of the new ’One Lonza’ structure and its financial performance in the fiscal year 2024 ...

The ’One Lonza’ model, which became effective from April 1, 2025, includes three Contract Development and Manufacturing Organization (CDMO) business segments and the soon-to-be-divested Capsules ...

For the first half of 2024, Lonza reported net sales of CHF 3.06 billion and core EBITDA of CHF 893 million, representing a margin of 29.2%. Again, Integrated Biologics led with CHF 1.34 billion in ...

Lonza Group AG, together with its subsidiaries ... and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments.

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Biologics CDMO Market - A Global and Regional Analysis: Focus on Cell Type, Indication, Molecule Type, and Region - Analysis and Forecast, 2025-2035" ...